Rosetta Genomics Ltd.
10 Plaut Street
Rehovot
76706
Tel: 972-0-8-9484755
Fax: 972-0-8-9484766
Website: http://www.rosettagenomics.com/
Email: contact@rosettagenomics.com
348 articles about Rosetta Genomics Ltd.
-
While the biopharma industry awaits news of an acquisition of Shire by Takeda Pharmaceuticals, it’s a good time to take a look back at the bigger deals so far this year.
-
Stockholders Approve Genoptix Acquisition of Rosetta Genomics
4/30/2018
Genoptix will immediately begin Marketing, Selling and Distributing the complete Rosetta Genomics Portfolio
-
Advaxis Taps Kenneth Berlin as New CEO
4/23/2018
After nearly a year without a permanent chief executive officer Advaxis, Inc. has a new hand on the wheel. This morning the company announced Kenneth A. Berlin will take over the helm of the company as president and CEO effective immediately. -
Genoptix Announces Termination of Merger Agreement with Rosetta Genomics and Now Focused on Next Steps
2/26/2018
Genoptix is the only secured creditor in all assets of Rosetta Genomics
-
Rosetta Genomics Fortifies Patent Protection For Its Unique RosettaGX Reveal Assay
3/20/2017
-
Rosetta Genomics Announces 1-for-12 Reverse Stock Split
3/16/2017
-
Rosetta Genomics Reports Preliminary RosettaGX Reveal Financial Results For The 2016 Fourth Quarter And Year
2/8/2017
-
Rosetta Genomics Announces Key U.S. Patent Allowances For Two RosettaGx Reveal microRNAs
2/6/2017
-
Rosetta Genomics Release: Aegis Restates "Buy" Rating On Shares Of Rosetta Genomics
1/12/2017
-
Rosetta Genomics Enters Research Collaboration Using Microrna Biomarkers To Predict Response To Leading Immuno-Oncology Drug Nivolumab In Lung Cancer Patients
11/21/2016
-
Rosetta Genomics Release: Clinical Validation Study For RosettaGX Reveal Published In The Journal Of Clinical Pathology
10/27/2016
-
Toft Group Completes Chief Commercial Officer Search For Rosetta Genomics In Princeton, NJ
10/25/2016
-
Rosetta Genomics Release: RosettaGX Reveal Analytical Validation Study Featured On The Cover Of The October Issue Of Cancer Cytopathology
10/24/2016
-
Rosetta Genomics Appoints Mark R. Willig As Chief Commercial Officer
10/20/2016
-
Rosetta Genomics Fortifies Intellectual Property Portfolio With Two New Patent Allowances For Its Novel MicroRNA Platform Technology
10/3/2016
-
Rosetta Genomics Enters Distribution Agreement For Rosettagx Reveal In Israel With Rhenium
9/29/2016
-
Rosetta Genomics To Host 2016 Second Quarter Financial Results And Business Update Conference Call On September 26, 2016
9/20/2016
-
Rosetta Genomics Release: Data Validating The Utility Of Rosettagx Reveal With Liquid-Based Cytology Samples Will Be Presented At The 86th Annual Meeting Of The American Thyroid Association
9/14/2016
-
Rosetta Genomics Release: RosettaGX Reveal Thyroid miRNA Classifier Now Available to Be Utilized on ThinPrep Samples
9/7/2016
-
Rosetta Genomics Selected By A Global Pharmaceutical Company To Supply FISH Testing Services For Clinical Study In Prostate Cancer
8/24/2016